Sandoz (United States)

Sandoz is a global leader in generic and biosimilar medicines, formerly the generics division of Novartis and now an independent company. Sandoz develops and manufactures affordable alternatives to brand-name pharmaceuticals across therapeutic categories including anti-infectives, cardiovascular, CNS, and immunology. The company’s biosimilar portfolio includes alternatives to biologics for cancer, autoimmune diseases, and other conditions.